All filters
Slidesets
Population Pharmacodynamics Modelling of Circulating Lymphocyte Count Over Time in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment - Fanny Gallais
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Challenges in the Development of Immunotherapy - Candice Jamois, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Optimal Study Design of Oncology Trials - Patricia LoRusso, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients - Félicien Le Louedec
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan - Ruben van Eerden
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Oral Targeted Oncolytics - Neeltje Steeghs, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib - Koen Hussaart
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Correlation Between Sunitinib Exposure and Toxicity in a Real-life Patient Cohort - Kim Westerdijk
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Drug - Food Interaction an Unrealized Potential - Nielka van Erp, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Oxazolidinones for TB: Current Status and Future Prospects - Lawrence Geiter
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Evaluating Hepatotoxicity of Bedaquiline Treatment in Multi-Drug Resistant Tuberculosis Patients - Lénaïg Tanneau
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Relationship Between Plasma and Intracellular Concentrations of Bedaquiline and its M2 Metabolite in South African Patients with Drug-Resistant TB - Precious Ngwalero
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Pharmacokinetics and Early Bactericidal Activity of Meropenem (with Amoxicillin/Clavulanate), With and Without Rifampicin, for Drug-Susceptible TB - Ahmed Aliyu Abulfathi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Co-Administration of Pretomanid with Rifampin or Rifabutin Among Patients with Pulmonary TB: Interim PK Results from “Assessing Pretomanid for Tuberculosis” (APT) Trial - Elisa Ignatius
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Exposures to First-Line Drugs in African and Indian Children with Drug-Susceptible Tuberculosis using Novel Fixed-Dose-Combination Tablets at WHO Dosing Recommendation in the SHINE Trial - Chishala Chabala
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Ethionamide Population Pharmacokinetic Model and Monte Carlo Simulation in Patients with Multidrug-Resistant Tuberculosis - Charles Peloquin
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Can Longitudinal PKPD Biomarkers be used to Forecast Treatment Outcome Instead of M2 Conversion? A Population Pharmacokinetic-Pharmacodynamic Analysis in Drug Sensitive Pulmonary Tuberculosis - Frank Kloprogge
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Pharmacokinetic-Pharmacodynamic Analysis in TB Drug Development and the Role of the WHO - Ernesto Jaramillo
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
PK-PD of Isoniazid Given at Different Doses Among Patients with MDR-TB with INH Resistance Mediated by inhA Mutations: Modeling Results from ACTG A5312 - Kamunkhwala Gausi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Population Pharmacokinetics of Linezolid in TB Patients: Dosing Regimens Simulation and Target Attainment Analysis - Charles Peloquin
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Drug Effect of Clofazimine on Persistent Mycobacteria Explain an Unexpected Increase of Bacterial Load in Patients - Alan Faraj
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Levofloxacin Target Attainment Analysis in MDR-TB Patients: Time is Ripe for Proactive TDM - Mathieu Bolhuis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019